NBEA

Chr 13AD

neurobeachin

Also known as: BCL8B, LYST2, NEDEGE

This gene encodes a member of a large, diverse group of A-kinase anchor proteins that target the activity of protein kinase A to specific subcellular sites by binding to its type II regulatory subunits. Brain-specific expression and coat protein-like membrane recruitment of a highly similar protein in mouse suggest an involvement in neuronal post-Golgi membrane traffic. Mutations in this gene may be associated with a form of autism. This gene and its expression are frequently disrupted in patients with multiple myeloma. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants may exist, but their full-length nature has not been determined.[provided by RefSeq, Feb 2011]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.071 OMIM phenotype
Clinical SummaryNBEA
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
92 unique Pathogenic / Likely Pathogenic· 624 VUS of 979 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.07LOEUF
pLI 1.000
Z-score 10.66
OE 0.04 (0.020.07)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
5.51Z-score
OE missense 0.60 (0.560.63)
875 obs / 1469.5 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.04 (0.020.07)
00.351.4
Missense OE?0.60 (0.560.63)
00.61.4
Synonymous OE?0.98
01.21.6
LoF obs/exp: 5 / 142.1Missense obs/exp: 875 / 1469.5Syn Z: 0.34
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongNBEA-related neurodevelopment disorder with seizuresLOFAD

This gene — mechanism propensity

DN
0.3296th %ile
GOF
0.4184th %ile
LOF
0.73top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 78% of P/LP variants are LoF · LOEUF 0.07 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Literature Evidence

LOFThese findings indicate that Nbea haploinsufficiency leads to various molecular and cellular changes that affect neuroplasticity and behavioral functions in mice, and could thus underlie the ASD symptomatology in NBEA deficient humans.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 23153818

ClinVar Variant Classifications

979 submitted variants in ClinVar

Classification Summary

Pathogenic42
Likely Pathogenic50
VUS624
Likely Benign195
Benign14
Conflicting20
42
Pathogenic
50
Likely Pathogenic
624
VUS
195
Likely Benign
14
Benign
20
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
36
5
1
0
42
Likely Pathogenic
36
11
3
0
50
VUS
10
587
23
4
624
Likely Benign
1
69
16
109
195
Benign
0
4
4
6
14
Conflicting
20
Total8367647119945

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

58 pathogenic / likely-pathogenic (of 67) ClinVar copy-number / structural variants overlap NBEA — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NBEA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.